Artesunate and artemether are effective fasciolicides in the rat model and in vitro

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 6, 2006, Pages 1139-1145

  Keiser, Jennifer ^a   Shu Hua, Xiao ^b   Tanner, Marcel ^a   Utzinger, Jürg ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Artemisinin; Dihydroartemisinin; Fasciola hepatica; Food borne trematodiasis; In vitro studies; In vivo studies; Scanning electron microscopy

Indexed keywords

ARTEMETHER; ARTESUNATE; DIHYDROARTEMISININ; FASCIOLICIDE; ANTIPLATYHELMINTIC AGENT; ARTEMISININ DERIVATIVE; DIHYDROQUINGHAOSU; SESQUITERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG EXPOSURE; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; SINGLE DRUG DOSE; ANIMAL; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; PARASITOLOGY; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; ANTIPLATYHELMINTIC AGENTS; ARTEMISININS; BILE DUCTS; DISEASE MODELS, ANIMAL; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; MICROSCOPY, ELECTRON, SCANNING; RATS; RATS, WISTAR; SESQUITERPENES;

EID: 33748902120     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl125     Document Type: Article

References (32)

1. Mas-Coma S. Human fascioliasis: Epidemiological patterns in human endemic areas of South America, Africa and Asia. Southeast Asian J Trop Med Public Health 2004; 35: 1-11.
2. Richter J, Knipper M, Goebels K et al. Fascioliasis. Curr Treat Options Infect Dis 2002; 4: 313-17.
3. Keiser J, Utzinger J. Emerging foodborne trematodiasis. Emerg Infect Dis 2005; 11: 1507-14.
4. WHO. Control of Foodborne Trematode Infections. Report of a WHO Study-Group. WHO Tech Rep Ser No. 849. Geneva: World Health Organization, 1995.
5. Esteban J-G, Gonzalez C, Curtale F et al. Hyperendemic fascioliasis associated with schistosomiasis in villages in the Nile Delta of Egypt. Am J Trop Med Hyg 2003; 69: 429-37.
6. Keiser J, Utzinger J. Chemotherapy for major food-borne trematodes: A review. Expert Opin Pharmacother 2004; 5: 1711-26.
7. Keiser J, Brun R, Fried B et al. Trematocidal activity of praziquantel and artemisinin derivatives: In vitro and in vivo investigations on adult Echinostoma caproni. Antimicrobial Agents Chemother 2006; 50: 803-5.
8. Apt W, Aguilera X, Vega F et al. Treatment of human chronic fascioliasis with triclabendazole: Drug efficacy and serologic response. Am J Trop Med Hyg 1995; 52: 532-5.
9. Chen MG, Mott K. Progress in assessment of morbidity due to Fasciola hepatica infection: A review of recent literature. Trop Dis Bull 1990; 87: 1-38.
10. Keiser J, Engels D, Büscher G et al. Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Invest Drugs 2005; 14: 1513-26.
11. Klayman DL. Qinghaosu (artemisinin): An antimalarial drug from China. Science 1985; 228: 1049-55.
12. Li Y, Wu YL. An over four millennium story behind qinghaosu (artemisinin) - a fantastic antimalarial drug from a traditional Chinese herb. Curr Med Chem 2003; 10: 2197-230.
13. de Vries PJ, Dien TK. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 1996; 52: 818-36.
14. Davis TM, Karunajeewa HA, Ilett KF. Artemisinin-based combination therapies for uncomplicated malaria. Med J Aust 2005; 182: 181-5.
15. Tinga N, De N, Vien HV et al. Little effect of praziquantel or artemisinin on clonorchiasis in Northern Vietnam. A pilot study. Trop Med Int Health 1999; 4: 814-8.
16. Meaney M, Fairweather I, Brennan GP et al. Fasciola hepatica: Effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young-and old-mature flukes. Parasitol Res 2003; 91: 238-50.
17. Meaney M, Haughey S, Brennan GP et al. Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica. Parasitol Res 2005; 95: 201-12.
18. Fairweather I. Triclabendazole: New skills to unravel an old(ish) enigma. J Helminthol 2005; 79: 227-34,
19. Li QG, Peggins JO, Fleckenstein LL et al. The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. J Pharm Pharmacol 1998; 50: 173-82.
20. Batty KT, Iletr KE, Powell SM et al. Relative bioavailability of artesunate and dihydroartemisinin: Investigations in the isolated perfused rat liver and in healthy Caucasian volunteers. Am J Trop Med Hyg 2002; 66: 130-6.
21. Maffei Facino R, Carini M. Loss of substrate binding capacity of the hepatic microsomal cytochrome P-450 in Fasciola hepatica infected rats: toxicological implications. Farmaco 1982; 37: 184-91.
22. Bapiro TE, Egnell AC, Hasler JA et al. Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos 2001; 29: 30-5.
23. Li XQ, Bjorkman A, Andersson TB et al. Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur J Clin Pharmacol 2003; 59: 429-42.
24. Burk O, Arnold KA, Nussler AK et al. Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol 2005; 67: 1954-65.
25. Olliaro PL, Nair NK, Sathasivam K et al. Pharmacokinetics of artesunate after single oral administration to rats. BMC Pharmacol 2001; 1: 12.
26. Newton P, Suputtamongkol Y, Teja-Isavadharm P et al. Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria. Antimicrob Agents Chemother 2000; 44: 972-7.
27. Schulman MD, Valentino D, Cifelli S et al. A pharmacokinetic basis for the efficacy of 4-amino-6-trichloroethenyl-1,3,-benzenedisulfonamide against Fasciola hepatica in the rat. J Parasitol 1979; 65: 555-61.
28. Utzinger J, Keiser J. Schistosomiasis and soil-transmitted helminthiasis: Common drugs for treatment and control. Expert Opin Pharmacother 2004; 5: 263-85.
29. Xiao SH. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Trop 2005; 96: 153-67.
30. Utzinger J, Chollet J, Tu ZW et al. Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice. Trans R Soc Trop Med Hyg 2002; 96: 318-23.
31. Xiao SH, Catto BA. In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob Agents Chemother 1989; 33: 1557-62.
32. Jiraungkoorskul W, Sahaphong S, Sobhon P et al. Effects of praziquantel and artesunate on the tegument of adult Schistosoma mekongi harboured in mice: Parasitol Int 2005; 54: 177-83.